The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Phase 1 · 48 people · 14 sites in United States · Recruiting now

November 3, 2026
Rectus Sheath Catheters Following Midline Laparotomy

Not phased · randomised · 40 people · 1 site in Germany · Recruiting now

November 3, 2026
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors

Phase 1 · 152 people · 2 sites in United States · Recruiting now

November 3, 2026
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

Phase 1 · 285 people · 6 sites in United States · Recruiting now

November 3, 2026
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Phase 1 · 130 people · 11 sites in 3 countries · Recruiting now

November 3, 2026
A Study of MGC030 in Participants With Advanced Solid Tumors

Phase 1 · 314 people · 1 site in United States · Recruiting now

November 3, 2026
A Study of LY4257496 in Participants With Cancer

Phase 1 · 421 people · 33 sites in 7 countries · Recruiting now

November 3, 2026
Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors

Phase 2 · 320 people · 1 site in United States · Recruiting now

November 3, 2026
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer

Phase 2 · 10 people · 1 site in Canada · Recruiting now

November 3, 2026
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

Phase 2 · 180 people · 9 sites in United States · Recruiting now

November 3, 2026